prior to now several years, the united kingdom has witnessed a revolution in health care fat‑reduction treatment options — with the introduction of semaglutide (Wegovy®) towards the rising attractiveness of tirzepatide (Mounjaro®). Now, Yet another title is drawing focus in both clinical and comm